Activated T cells and cytokine-induced CD3+CD56+ killer cells G. D. Schmidt-WolfR. S. NegrinI. G. H. Schmidt-Wolf REVIEW ARTICLE Pages: 51 - 56
Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expression V. NüsslerF. GieselerW. Wilmanns ORIGINAL ARTICLE Pages: 57 - 64
Multidrug resistance gene expression in acute myeloid leukemia: Major prognosis significance for in vivo drug resistance to induction treatment M. HunaultD. ZhouJ.-P. Marie ORIGINAL ARTICLE Pages: 65 - 71
Early-onset secondary malignancies after high-dose chemotherapy and autologous hematopoietic stem cell transplantation S. FetscherJ. FinkeW. Lange ORIGINAL ARTICLE Pages: 73 - 77
Alternating mini-BEAM/ESHAP as salvage therapy for refractory non-Hodgkin's lymphomas M. D. CaballeroM. L. AmigoJ. F. San Miguel ORIGINAL ARTICLE Pages: 79 - 82
The putative role of arylsulfatase in interleukin-2- mediated cytotoxicity and interleukin-7-mediated bactericidal activity of natural killer cells A. TorenM. GadishA. Nagler ORIGINAL ARTICLE Pages: 83 - 87
Acquired factor VIII inhibitors in nonhemophilic patients D. SöhngenC. SpeckerW. Schneider ORIGINAL ARTICLE Pages: 89 - 93
Myelodysplastic syndrome presenting as third malignancy after non-Hodgkin's lymphoma and osteosarcoma M. KubotaM. SawadaK. Furusho CASE REPORT Pages: 95 - 97
Cytomegalovirus-associated myelodysplasia and thrombocytopenia in an immunocompetent adult M. MiyaharaY. ShimamotoK. Ono CASE REPORT Pages: 99 - 101